Stability of Employment Status Among Patients with Highly Active Relapsing Multiple Sclerosis During the 2-year CLARIFY-MS Study

被引：0
|
作者：
Selmaj, K. [1 ]
Langdon, D. [2 ]
Brochet, B. [3 ]
Havrdova, E. K. [4 ]
Lechner-Scott, J. [5 ,6 ]
Montalban, X. [7 ]
Patti, F. [8 ,9 ]
Piehl, F. [10 ]
Solari, A. [11 ]
Alexandri, N. [12 ]
Nolting, A. [12 ]
Lehn, A. [12 ]
Smyk, A. [12 ]
机构：
[1] Ctr Neurol, Lodz, Poland
[2] Royal Holloway Univ London, Dept Psychol, Egham, Surrey, England
[3] Univ Bordeaux, INSERM U 1215, Bordeaux, France
[4] Charles Univ Prague, Med Fac 1, Prague, Czech Republic
[5] Univ Newcastle, Newcastle, NSW, Australia
[6] John Hunter Hosp, Div Neurol, Newcastle, NSW, Australia
[7] Univ Hosp Vall Hebron, Dept Neurol Neuroimmunol, Ctr Multiple Sclerosis Catalonia Cemcat, Barcelona, Spain
[8] Univ Catania, GF Ingrassia, Dept Med & Surg Sci & Adv Technol, Catania, Italy
[9] Univ Catania, Azienda Osped Univ Policlin G Rodolico San Marco, Catania, Italy
[10] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden
[11] Fdn IRCCS Ist Neurol Carlo Bes, Unit Neuroepidemiol, Milan, Italy
[12] Healthcare Business Merck KGaA, Darmstadt, Germany
来源：
MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P089
引用
收藏
页码：60 / 60
页数：1
相关论文
共 50 条
  • [21] Predictors of quality of life in patients with relapsing-remitting multiple sclerosis: A 2-year longitudinal study
    Baumstarck, K.
    Pelletier, J.
    Boucekine, M.
    Auquier, P.
    REVUE NEUROLOGIQUE, 2015, 171 (02) : 173 - 180
  • [22] OCT Analysis in Patients with Relapsing-Remitting Multiple Sclerosis during Fingolimod Therapy: 2-Year Longitudinal Retrospective Study
    Rossi, Settimio
    Gesualdo, Carlo
    Gallo, Antonio
    Melillo, Paolo
    Martines, Francesco
    Colucci, Raffaella
    D'Ambrosio, Alessandro
    Tedeschi, Gioacchino
    Simonelli, Francesca
    APPLIED SCIENCES-BASEL, 2020, 10 (20): : 1 - 9
  • [23] Uric acid in relapsing-remitting multiple sclerosis: a 2-year longitudinal study
    Moccia, Marcello
    Lanzillo, Roberta
    Costabile, Teresa
    Russo, Cinzia
    Carotenuto, Antonio
    Sasso, Gabriella
    Postiglione, Emanuela
    Picione, Carla De Luca
    Vastola, Michele
    Maniscalco, Giorgia Teresa
    Palladino, Raffaele
    Morra, Vincenzo Brescia
    JOURNAL OF NEUROLOGY, 2015, 262 (04) : 961 - 967
  • [24] The effect of natalizumab on brain atrophy in patients with relapsing multiple sclerosis: 2-year results from the AFFIRM study
    Fisher, E
    O'Connor, R
    Havrdova, E
    Hutchinson, M
    Kappos, L
    Miller, D
    Phillips, JT
    Polman, C
    Lublin, R
    Giovannoni, G
    Wajgt, A
    Rudick, R
    Lynn, F
    Toal, M
    Panzara, M
    Sandrock, A
    JOURNAL OF NEUROLOGY, 2005, 252 : 149 - 149
  • [25] A longitudinal study of cortical atrophy in patients with relapsing-remitting multiple sclerosis over a 2-year period
    Zivadinov, R.
    Dolezal, O.
    Tekwe, C. I.
    Horakova, D.
    Dwyer, M. G.
    Balachandran, S.
    Bergsland, N.
    Havrdova, E.
    JOURNAL OF NEUROLOGY, 2006, 253 : 56 - 57
  • [26] The MS@Work study - predictors of employment status and work absenteeism in relapsing-remitting Multiple Sclerosis
    van Gorp, D.
    van der Hiele, K.
    Heerings, M.
    Jongen, P.
    van Lieshout, I.
    Vosman, F.
    Reneman, M.
    van der Klink, J.
    Middelkoop, H.
    Visser, L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 396 - 396
  • [27] Physical and Cognitive Predictors of Employment Status in Relapsing-Remitting Multiple Sclerosis Patients: A 7-Year Longitudinal Study
    Ruet, Aurelie
    Hamel, Delphine
    Deloire, Mathilde
    Brochet, Bruno
    NEUROLOGY, 2011, 76 (09) : A484 - A484
  • [28] Clinical and MRI predictors of cognitive decline in patients with relapsing-remitting multiple sclerosis: A 2-year longitudinal study
    Dong, Xiaoli
    Xu, Guodong
    Wang, Jia
    Yin, Nan
    Meng, Nan
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 65
  • [29] Blood biomarker dynamics in people with relapsing multiple sclerosis treated with cladribine tablets: results of the 2-year MAGNIFY-MS study
    Wiendl, Heinz
    Barkhof, Frederik
    Montalban, Xavier
    Achiron, Anat
    Derfuss, Tobias
    Chan, Andrew
    Hodgkinson, Suzanne
    Prat, Alexandre
    Leocani, Letizia
    Schmierer, Klaus
    Sellebjerg, Finn
    Vermersch, Patrick
    Jin, Hulin
    Chudecka, Anita
    Kloetgen, Andreas
    Lin, Dongdong
    Gardner, Lidia
    De Stefano, Nicola
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [30] Five-year study of adherence to disease-modifying therapies in patients with relapsing multiple sclerosis: 2-year interim results
    Ramo, C.
    Arroyo, E.
    Sanchez-Solino, O.
    JOURNAL OF NEUROLOGY, 2009, 256 : S125 - S125
12345